156 related articles for article (PubMed ID: 9449013)
1. Development of a therapeutic vaccine for the treatment of cocaine addiction.
Fox BS
Drug Alcohol Depend; 1997 Dec; 48(3):153-8. PubMed ID: 9449013
[TBL] [Abstract][Full Text] [Related]
2. Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010.
Kantak KM; Collins SL; Bond J; Fox BS
Psychopharmacology (Berl); 2001 Jan; 153(3):334-40. PubMed ID: 11271406
[TBL] [Abstract][Full Text] [Related]
3. Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence reported by Fox, Gorelick and Cohen in the immediately succeeding articles (see pages 153-174).
Sparenborg S; Vocci F; Zukin S
Drug Alcohol Depend; 1997 Dec; 48(3):149-51. PubMed ID: 9449012
[No Abstract] [Full Text] [Related]
4. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence.
Hall W; Carter L
J Med Ethics; 2004 Aug; 30(4):337-40. PubMed ID: 15289512
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model.
Kantak KM; Collins SL; Lipman EG; Bond J; Giovanoni K; Fox BS
Psychopharmacology (Berl); 2000 Feb; 148(3):251-62. PubMed ID: 10755738
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a therapeutic cocaine vaccine in rodent models.
Fox BS; Kantak KM; Edwards MA; Black KM; Bollinger BK; Botka AJ; French TL; Thompson TL; Schad VC; Greenstein JL; Gefter ML; Exley MA; Swain PA; Briner TJ
Nat Med; 1996 Oct; 2(10):1129-32. PubMed ID: 8837612
[TBL] [Abstract][Full Text] [Related]
7. Cocaine vaccines: antibody protection against relapse in a rat model.
Carrera MR; Ashley JA; Zhou B; Wirsching P; Koob GF; Janda KD
Proc Natl Acad Sci U S A; 2000 May; 97(11):6202-6. PubMed ID: 10823960
[TBL] [Abstract][Full Text] [Related]
8. Anti-cocaine vaccines: antibody protection against relapse.
Kantak KM
Expert Opin Pharmacother; 2003 Feb; 4(2):213-8. PubMed ID: 12562311
[TBL] [Abstract][Full Text] [Related]
9. Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus.
Koob G; Hicks MJ; Wee S; Rosenberg JB; De BP; Kaminsky SM; Moreno A; Janda KD; Crystal RG
CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):899-904. PubMed ID: 22229312
[TBL] [Abstract][Full Text] [Related]
10. The future potential for cocaine vaccines.
Orson FM; Wang R; Brimijoin S; Kinsey BM; Singh RA; Ramakrishnan M; Wang HY; Kosten TR
Expert Opin Biol Ther; 2014 Sep; 14(9):1271-83. PubMed ID: 24835496
[TBL] [Abstract][Full Text] [Related]
11. AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.
Rosenberg JB; Hicks MJ; De BP; Pagovich O; Frenk E; Janda KD; Wee S; Koob GF; Hackett NR; Kaminsky SM; Worgall S; Tignor N; Mezey JG; Crystal RG
Hum Gene Ther; 2012 May; 23(5):451-9. PubMed ID: 22486244
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques.
Evans SM; Foltin RW; Hicks MJ; Rosenberg JB; De BP; Janda KD; Kaminsky SM; Crystal RG
Pharmacol Biochem Behav; 2016; 150-151():76-86. PubMed ID: 27697554
[TBL] [Abstract][Full Text] [Related]
13. A shot against cocaine addiction.
Lab Anim (NY); 2001 Apr; 30(4):12-3. PubMed ID: 11385738
[No Abstract] [Full Text] [Related]
14. Efficacy and side effects of baclofen and the novel GABA
Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R
Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507
[TBL] [Abstract][Full Text] [Related]
15. Predicting the clinical efficacy and potential adverse effects of a humanized anticocaine monoclonal antibody.
Norman AB; Ball WJ
Immunotherapy; 2012 Mar; 4(3):335-43. PubMed ID: 22401638
[TBL] [Abstract][Full Text] [Related]
16. Immunization for prevention and treatment of cocaine abuse: legal and ethical implications.
Cohen PJ
Drug Alcohol Depend; 1997 Dec; 48(3):167-74. PubMed ID: 9449015
[TBL] [Abstract][Full Text] [Related]
17. Cocaine pharmacology and current pharmacotherapies for its abuse.
Carrera MR; Meijler MM; Janda KD
Bioorg Med Chem; 2004 Oct; 12(19):5019-30. PubMed ID: 15351386
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic vaccines for substance dependence.
Kosten TR; Biegel D
Expert Rev Vaccines; 2002 Oct; 1(3):363-71. PubMed ID: 12901575
[TBL] [Abstract][Full Text] [Related]
19. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
Xi ZX; Newman AH; Gilbert JG; Pak AC; Peng XQ; Ashby CR; Gitajn L; Gardner EL
Neuropsychopharmacology; 2006 Jul; 31(7):1393-405. PubMed ID: 16205781
[TBL] [Abstract][Full Text] [Related]
20. The dopamine D1 receptor agonist and D2 receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats.
Milivojevic N; Krisch I; Sket D; Zivin M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):576-82. PubMed ID: 15138661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
